79 related articles for article (PubMed ID: 3369875)
1. [A case of recurrent ovarian cancer successfully treated with etoposide].
Wakisaka T; Sou S
Gan To Kagaku Ryoho; 1988 May; 15(5):1795-8. PubMed ID: 3369875
[TBL] [Abstract][Full Text] [Related]
2. [A case of stage III ovarian carcinoma successfully treated with oral etoposide].
Takeda S; Takada S; Kojima T; Kinoshita K; Sakamoto S
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1929-31. PubMed ID: 2393311
[TBL] [Abstract][Full Text] [Related]
3. [A case of recurrent uterine cervical cancer successfully treated with etoposide].
Kobayashi H; Kawashima Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3279-82. PubMed ID: 2782919
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent endometrial cancer successfully treated with oral administration of etoposide].
Tsuruchi N; Jimi S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):103-5. PubMed ID: 1729957
[TBL] [Abstract][Full Text] [Related]
5. [A case of recurrent ovarian cancer markedly responding to daily oral administration of low dose etoposide].
Fujita H; Ito R; Yamamoto T; Okada H
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2261-4. PubMed ID: 2241191
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide].
Ishizaki T; Yamamoto T; Itoh R; Yasuda J; Fujita H; Okada H
Gan To Kagaku Ryoho; 1995 Jan; 22(1):137-40. PubMed ID: 7826070
[TBL] [Abstract][Full Text] [Related]
7. Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival.
Mikami M; Komuro Y; Sakaiya N; Tei C; Kurahashi T; Komiyama S; Hirose T
Gynecol Oncol; 2001 Oct; 83(1):149-52. PubMed ID: 11585429
[TBL] [Abstract][Full Text] [Related]
8. [Oral etoposide therapy in stage III-IV ovarian carcinoma].
Takeda S; Takada S; Kojima T; Kinoshita K; Sakamoto S
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2562-6. PubMed ID: 2262736
[TBL] [Abstract][Full Text] [Related]
9. Daily low-dose oral etoposide for recurrent epithelial ovarian cancer after platinum-based therapy.
Moosavi AS; Gilani MM; Tehranian A; Esfahani JK
J Obstet Gynaecol; 2004 Apr; 24(3):292-3. PubMed ID: 15203631
[TBL] [Abstract][Full Text] [Related]
10. [A case of poorly differentiated ovarian serous adenocarcinoma responding favorably to etoposide and cisplatin].
Sato Y; Nishida M; Inoue K; Arai Y; Sasaki J; Kubo T
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1847-9. PubMed ID: 8937497
[TBL] [Abstract][Full Text] [Related]
11. [Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Akiyama J; Sagara Y; Takeda Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):521-6. PubMed ID: 6422860
[TBL] [Abstract][Full Text] [Related]
12. [A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy].
Fujimoto A; Saitou M; Ishihara O; Takeda S; Kinoshita K; Itoyama S
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1843-6. PubMed ID: 7574820
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer.
de Jong RS; Hofstra LS; Willemse PH; de Bruijn HW; de Vries EG; Boonstra H; Mulder NH
Gynecol Oncol; 1997 Aug; 66(2):197-201. PubMed ID: 9264562
[TBL] [Abstract][Full Text] [Related]
14. [A case of complete remission obtained with etoposide in uterine choriocarcinoma].
Kikuchi J; Sasaki T; Ishibashi K; Takaya R; Mori H; Endo H; Shima I; Moritsuka T; Takahashi K
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1209-12. PubMed ID: 2053779
[TBL] [Abstract][Full Text] [Related]
15. [CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report].
Beppu M; Hiura M; Nogawa T; Kawakami Y; Yokoyama T; Chiba T
Gan To Kagaku Ryoho; 1998 May; 25(6):933-6. PubMed ID: 9617335
[TBL] [Abstract][Full Text] [Related]
16. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
17. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Rose PG; Rodriguez M; Walker J; Greer B; Fusco N; McGuire W
Gynecol Oncol; 2002 Apr; 85(1):136-9. PubMed ID: 11925133
[TBL] [Abstract][Full Text] [Related]
19. [A case of curatively operated gastric cancer with peritonitis carcinomatosa treated by intraperitoneal administration of CDDP.Etoposide and EAP therapy].
Sakata Y; Okamura T; Kurimoto H; Ono K; Uenishi M
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2829-32. PubMed ID: 7993123
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
